ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $212,139 | +5700.9% | 8,375 | +5716.0% | 0.00% | – |
Q1 2024 | $3,657 | -94.8% | 144 | -95.4% | 0.00% | -100.0% |
Q4 2023 | $70,336 | +226.3% | 3,104 | +168.3% | 0.00% | 0.0% |
Q3 2023 | $21,555 | -74.4% | 1,157 | -64.4% | 0.00% | -66.7% |
Q2 2023 | $84,331 | +401476.2% | 3,246 | +350.8% | 0.00% | +200.0% |
Q1 2023 | $21 | -83.6% | 720 | -83.2% | 0.00% | -80.0% |
Q4 2022 | $128 | -99.7% | 4,295 | +168.3% | 0.01% | +400.0% |
Q3 2022 | $38,000 | +72.7% | 1,601 | +61.2% | 0.00% | – |
Q2 2022 | $22,000 | -56.9% | 993 | -51.7% | 0.00% | – |
Q1 2022 | $51,000 | -5.6% | 2,056 | +36.4% | 0.00% | -100.0% |
Q4 2021 | $54,000 | +8.0% | 1,507 | +27.0% | 0.00% | 0.0% |
Q3 2021 | $50,000 | +56.2% | 1,187 | +60.2% | 0.00% | 0.0% |
Q2 2021 | $32,000 | +52.4% | 741 | +39.8% | 0.00% | – |
Q1 2021 | $21,000 | +16.7% | 530 | +30.5% | 0.00% | -100.0% |
Q4 2020 | $18,000 | 0.0% | 406 | -21.3% | 0.00% | – |
Q3 2020 | $18,000 | -76.6% | 516 | -74.7% | 0.00% | -100.0% |
Q2 2020 | $77,000 | +208.0% | 2,040 | +320.6% | 0.00% | +50.0% |
Q4 2019 | $25,000 | +127.3% | 485 | +140.1% | 0.00% | +100.0% |
Q3 2019 | $11,000 | +57.1% | 202 | -1.0% | 0.00% | 0.0% |
Q4 2018 | $7,000 | -94.0% | 204 | -94.4% | 0.00% | -83.3% |
Q2 2018 | $116,000 | +866.7% | 3,626 | +1548.2% | 0.01% | +200.0% |
Q4 2017 | $12,000 | -90.5% | 220 | -89.8% | 0.00% | -80.0% |
Q3 2017 | $126,000 | +250.0% | 2,165 | +220.7% | 0.01% | +233.3% |
Q2 2016 | $36,000 | +800.0% | 675 | +575.0% | 0.00% | +200.0% |
Q1 2016 | $4,000 | -82.6% | 100 | -83.6% | 0.00% | -75.0% |
Q4 2015 | $23,000 | -32.4% | 610 | -40.5% | 0.00% | +33.3% |
Q2 2015 | $34,000 | +78.9% | 1,026 | +126.0% | 0.00% | +50.0% |
Q1 2015 | $19,000 | +46.2% | 454 | +40.6% | 0.00% | +100.0% |
Q4 2014 | $13,000 | +550.0% | 323 | +456.9% | 0.00% | – |
Q3 2014 | $2,000 | -84.6% | 58 | -79.1% | 0.00% | -100.0% |
Q2 2014 | $13,000 | -60.6% | 277 | -65.4% | 0.00% | -50.0% |
Q1 2014 | $33,000 | +13.8% | 801 | +4.6% | 0.00% | -20.0% |
Q4 2013 | $29,000 | -54.0% | 766 | -70.6% | 0.01% | -28.6% |
Q3 2013 | $63,000 | +2000.0% | 2,602 | +1395.4% | 0.01% | – |
Q2 2013 | $3,000 | – | 174 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |